FRA:M12

M1 Kliniken AG Stock Insider Trading

17.85€

-2.65 (-12.93%)

At Close: Jun 21, 2024

M1 Kliniken AG Stock Insider Power

Based on the 0 latest insides trades, we have calculated the insider power to be negative at 0. In total, the insiders bought 0 and sold 0 M12.F shares in the last 0 trades.

Historical Insider Trades

There is currently no insider trading information for this ticker.

However, we invite you to learn more about this term and how to use this knowledge to benefit your trading strategy:

Sorry! Image not available at this moment

About M1 Kliniken AG

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine,... M12.F Profile

Golden Star

Ticker	Date	Change	Price
V	Jun 18	0.585%	$273.62
EPD	Jun 18	0.95%	$28.30
USFD	Jun 18	0.565%	$53.14
RGA	Jun 17	1.62%	$203.90
MA	Jun 17	1.50%	$448.11
BR	Jun 17	1.59%	$197.65
^DJI	Jun 17	0.92%	38,778.10 points
SARK	Jun 17	1.85%	$30.34
DRI	Jun 14	3.02%	$148.78
BXSL	Jun 14	1.56%	$31.33

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by

Sign In